Veterinary Stereotactic Radiosurgery Systems Market - Global Strategic Business Report

The global market for Veterinary Stereotactic Radiosurgery Systems was valued at US$3.1 Billion in 2024 and is projected to reach US$5.3 Billion by 2030, growing at a CAGR of 9.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Veterinary Stereotactic Radiosurgery Systems market.

Global Veterinary Stereotactic Radiosurgery System Market - Key Trends & Drivers Summarized

Why Is Stereotactic Radiosurgery Revolutionizing Veterinary Oncology?

Stereotactic radiosurgery (SRS) has emerged as a groundbreaking treatment option in veterinary oncology, offering a highly precise, non-invasive alternative to conventional surgery and radiation therapy. This advanced technique utilizes focused radiation beams to target tumors with pinpoint accuracy, minimizing damage to surrounding healthy tissues while effectively destroying cancerous cells. Veterinary SRS is particularly beneficial for treating brain tumors, nasal tumors, and osteosarcomas, where traditional surgical options are either too invasive or pose significant risks. The ability of SRS to deliver high-dose radiation in a single or limited number of sessions significantly reduces treatment times, making it a more convenient option for both veterinarians and pet owners. Additionally, SRS is being explored for non-oncological applications, such as treating neurological disorders and pain management in animals with inoperable spinal conditions. With the rising incidence of cancer in companion animals, driven by increasing pet longevity and improved diagnostic capabilities, stereotactic radiosurgery is becoming an essential tool in advanced veterinary care, offering new hope for pets diagnosed with previously untreatable conditions.

What Are the Technological Advancements Driving Veterinary Stereotactic Radiosurgery?

The field of veterinary SRS has seen remarkable technological advancements, improving treatment precision, safety, and accessibility. One of the most significant developments is the integration of real-time image-guided radiation therapy (IGRT), which allows veterinarians to continuously track tumor position during treatment, ensuring optimal accuracy. The use of high-resolution computed tomography (CT) and magnetic resonance imaging (MRI) for treatment planning has further enhanced the precision of SRS, enabling highly targeted radiation delivery with minimal collateral damage. The adoption of robotic radiosurgery platforms, such as CyberKnife, has revolutionized veterinary oncology by providing automated, real-time adjustments to compensate for patient movement during treatment. Additionally, advancements in radiation dose modulation and intensity-modulated radiosurgery (IMRS) have improved treatment effectiveness while reducing side effects. The increasing availability of dedicated veterinary radiation oncology centers equipped with cutting-edge SRS systems is also expanding access to this life-saving treatment. As these technologies continue to evolve, veterinary stereotactic radiosurgery is becoming an increasingly viable option for treating complex tumors and neurological disorders in animals.

What Challenges Are Limiting the Expansion of Veterinary Stereotactic Radiosurgery?

Despite its transformative potential, the adoption of veterinary SRS faces several significant challenges. One of the biggest barriers is the high cost of acquiring and maintaining SRS systems, making this treatment option accessible primarily in well-funded specialty hospitals and academic institutions. The complex nature of SRS also requires highly trained radiation oncologists and physicists, leading to a shortage of qualified veterinary professionals capable of performing these procedures. Additionally, while SRS provides a non-invasive alternative to conventional surgery, some tumors may still require adjunct therapies, such as chemotherapy or immunotherapy, increasing overall treatment costs for pet owners. Limited insurance coverage for advanced radiation therapy in veterinary medicine further restricts access to SRS, as many pet owners struggle to afford the high costs associated with precision oncology treatments. Another challenge is the need for continued research into the long-term effects of stereotactic radiosurgery in veterinary patients, as data on survival rates and post-treatment quality of life remains limited compared to human oncology studies. Overcoming these challenges will require increased investment in veterinary radiation oncology training, broader insurance coverage, and ongoing research into optimizing SRS treatment protocols for different animal species.

What Are the Key Growth Drivers of the Veterinary Stereotactic Radiosurgery Market?

The growth in the veterinary stereotactic radiosurgery system market is driven by several factors, including rising cancer rates in pets, advancements in radiation therapy technology, and increasing investment in veterinary specialty care. The growing prevalence of oncology-focused veterinary hospitals has expanded access to SRS, making it a viable treatment option for more pet owners. Technological innovations in robotic radiosurgery, real-time imaging, and automated treatment planning have further improved the safety and efficacy of SRS procedures. Additionally, the increasing willingness of pet owners to pursue advanced cancer treatments, coupled with the expanding availability of pet insurance coverage for radiation therapy, is fueling market growth. As veterinary oncology continues to evolve, the demand for precise, non-invasive cancer treatments will drive further adoption of stereotactic radiosurgery, solidifying its role as a cornerstone of modern veterinary medicine.

Report Scope

The report analyzes the Veterinary Stereotactic Radiosurgery Systems market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy / Flash-RT, CyberKnife); End-Use (Hospitals & Clinics, Academic & Research Institutions).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Some of the 36 companies featured in this Veterinary Stereotactic Radiosurgery Systems market report include -

• Accuray Incorporated
• ALCEN
• Arthrex Vet Systems
• C.R. Bard Inc.
• CIVCO Radiotherapy
• Elekta AB
• Ion Beam Applications SA
• Medtronic
• Nanovi Radiotherapy A/S
• PetCure Oncology
• ProBeam
• RaySearch Laboratories
• Stereotactic Radiosurgery Systems
• Varian Medical Systems, Inc.
• ViewRay
• Xcision Medical Systems
• Xstrahl
• VetCure Oncology
• GammaVet
• RadVet

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Gamma Knife segment, which is expected to reach US$2.4 Billion by 2030 with a CAGR of a 11.6%. The LINAC segment is also set to grow at 7.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $840.5 Million in 2024, and China, forecasted to grow at an impressive 13.3% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Veterinary Stereotactic Radiosurgery Systems Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Veterinary Stereotactic Radiosurgery Systems Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Veterinary Stereotactic Radiosurgery Systems Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as AccuPath Group Co., Ltd., AbtVet (Stening Group), Alibaba Group Holding Ltd., Arthrex Vet Systems, Create Medic Co., Ltd. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 36 Featured):

• Accuray Incorporated
• ALCEN
• Arthrex Vet Systems
• C.R. Bard Inc.
• CIVCO Radiotherapy
• Elekta AB
• Ion Beam Applications SA
• Medtronic
• Nanovi Radiotherapy A/S
• PetCure Oncology
• ProBeam
• RaySearch Laboratories
• Stereotactic Radiosurgery Systems
• Varian Medical Systems, Inc.
• ViewRay
• Xcision Medical Systems
• Xstrahl
• VetCure Oncology
• GammaVet
• RadVet

This edition integrates the latest global trade and economic shifts into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes historical analysis from 2015 to 2023.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.